NLS Pharmaceutics AG (NLSP) Cash Flow Statement Analysis - Operating Cash Flow, CapEx & Free Cash Flow - Stocknear

NLS Pharmaceutics AG

NASDAQ: NLSP · Real-Time Price · USD
2.00
-0.12 (-5.66%)
At close: Oct 03, 2025, 3:59 PM
1.98
-0.75%
After-hours: Oct 03, 2025, 07:41 PM EDT

NLS Pharmaceutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q4 2024 Q2 2024 Q4 2023 Q2 2023 Q4 2022 Q2 2022 Q4 2021 Q2 2021
Period Ending Dec 31, 2024 Jun 30, 2024 Dec 31, 2023 Jun 30, 2023 Dec 31, 2022 Jun 30, 2022 Dec 31, 2021 Jun 30, 2021
Net Income
55.02K -2.04M -4.56K -7.61M -7.85M -8.64M -7.34M -4.6M
Depreciation & Amortization
-2.38K 5.7K 5.70 5.7K 5.7K 5.7K 5.03K 5.02K
Stock-Based Compensation
67.07K n/a 104.39 60.52 22.73 n/a n/a n/a
Other Working Capital
-253.72K 449.46K 465.79K -474.33K 794.6K 195.94K 903.4K -1.78M
Other Non-Cash Items
-2.6M 99.42K -4.37M -683.26K 1.15M -784.54K -1.15M 3.63M
Deferred Income Tax
n/a n/a n/a 728.28K -160.01K n/a n/a n/a
Change in Working Capital
-253.72K 400.21K 1.99M 265.42K 646.02K 980.79K 2.1M -5.27M
Operating Cash Flow
-2.74M -1.53M -2.39M -7.3M -6.21M -7.67M -5.2M -9.73M
Capital Expenditures
-3.92K n/a 2.39M n/a n/a n/a -6.8K -32.76K
Cash Acquisitions
n/a n/a n/a n/a n/a n/a n/a n/a
Purchase of Investments
n/a n/a n/a n/a n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a n/a n/a n/a n/a
Other Investing Acitivies
n/a n/a n/a n/a n/a n/a n/a n/a
Investing Cash Flow
-3.92K n/a n/a n/a -7.6M 4.08M -6.8K -32.76K
Debt Repayment
194.72K -194.72K n/a n/a n/a n/a n/a -1.43K
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
n/a n/a 1.63M n/a 13.81M 3.59K 3.55M 16.79M
Financial Cash Flow
3.85M 1.19M 1.63M n/a 13.81M 3.59M 3.55M 16.79M
Net Cash Flow
1.11M -344.92K -753.77K -7.3M 7.59M -4.08M -1.66M 7M
Free Cash Flow
-2.74M -1.53M -2.39K -7.3M -6.21M -7.67M -5.21M -9.77M